Integrative Single-Cell Analysis of Transcriptome, Epigenome, and Lineage in HIV Latency and Activation
HIV 潜伏期和激活过程中转录组、表观基因组和谱系的综合单细胞分析
基本信息
- 批准号:10543067
- 负责人:
- 金额:$ 69.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-12-19 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAcuteAddressAffectAtlasesBasic ScienceBiochemicalBioinformaticsBiological MarkersCell LineageCell SeparationCell modelCellsChromatinChromiumClinical TreatmentClonal ExpansionComplementComputer ModelsComputing MethodologiesDNADataDevelopmentDiseaseFoundationsGene ExpressionGenesGenetic TranscriptionGenomeGoalsGranulocyte-Macrophage Colony-Stimulating FactorHIVHistone Deacetylase InhibitorHumanIn VitroInfectionLinkMacrophageMapsMarker DiscoveryMethodsModelingPatientsPatternPopulationProvirusesRNAReporterResidual stateSamplingShockSiteSurveysSystemTNF geneTimeViralViral GenomeViral reservoirVirionVirus ActivationVirus IntegrationVirus LatencyWorkXCL1 geneantiretroviral therapybiomarker identificationcell typecomputer frameworkenv Gene Productsepigenomeepigenomicshematopoietic differentiationinsightintegration sitelatent infectionmultiple omicsnovelsingle cell analysissingle-cell RNA sequencingtranscriptometranscriptomics
项目摘要
Abstract
With the development of triple combination antiretroviral therapy, routine HIV treatment eliminates nearly all
actively infected cells. Nevertheless, the small reservoir of latently infected cells, which can remain dormant for
long periods of time before becoming active and producing new virus particles, represents a crucial barrier to
completely curing the disease. Identifying markers that identify latently infected cells or the biochemical factors
that control latency activation could enable the effective use of a “shock and kill” strategy, where specific targeting
or activation of latently infected cells eliminates the viral reservoir. Our recent work suggests that the global
transcriptomic and epigenomic changes during hematopoietic differentiation affect viral latency and activation.
Additionally, we recently found that global inhibition of histone deacetylase activity increases viral activation in
these cells, further implicating epigenomic changes in activation. These results raise fundamental questions:
What are the markers of latently infected cells? How do the transcriptomic and epigenomic state of a cell affect
latency and activation? How does differentiation state relate to viral latency? Here, we leverage our experimental
platform for identifying latently and actively infected cells, single cell transcriptome and epigenome sequencing,
and our recently developed computational integration methods to investigate these questions. Our
interdisciplinary team combines expertise in HIV basic science, HIV clinical treatment, and bioinformatics to
develop an experimental and computational framework for integrated gene expression, chromatin accessibility,
and lineage into a single picture of viral latency and activation. Specifically, this project will (1) use single-cell
RNA-seq and single-cell ATAC-seq to map diversity of infected cells, (2) investigate the relationship between
hematopoietic differentiation state and viral activation, (3) determine viral integration sites through single-cell
RNA-seq, (4) computationally integrate single cell transcriptome and epigenome profiles, and (5) computationally
infer cell lineage relationships among viral genomes and infected cells. To accomplish these goals, we will carry
out the following aims: (1) Characterize lineage, transcriptomic and epigenomic diversity of single latently and
actively infected primary cells. (2) Investigate latency and activation during in vitro differentiation. (3) Survey
single cell diversity of re-activated and in vitro infected cells from cART-suppressed patients. Together, these
aims will produce a comprehensive, integrated transcriptomic and epigenomic atlas of the HIV reservoir, identify
DNA and RNA biomarkers of latency, and characterize clonal expansion patterns. Our work also develops a
broadly applicable experimental and computational framework, laying a foundation for the discovery of novel
insights into HIV latency and activation.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen L. Collins其他文献
A deliberate path toward diversity, equity, and inclusion within the ASCI.
ASCI 内一条通向多样性、公平性和包容性的深思熟虑的道路。
- DOI:
10.1172/jci142423 - 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
L. Ware;Kathleen L. Collins;J. Hawley;R. Ahima - 通讯作者:
R. Ahima
A year at the helm
掌舵一年
- DOI:
10.1172/jci.insight.142915 - 发表时间:
2020 - 期刊:
- 影响因子:8
- 作者:
Kathleen L. Collins - 通讯作者:
Kathleen L. Collins
Kathleen L. Collins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen L. Collins', 18)}}的其他基金
Single-cell multi-omic analysis of opioid-mediated HIV disease pathogenesis
阿片类药物介导的 HIV 疾病发病机制的单细胞多组学分析
- 批准号:
10813914 - 财政年份:2023
- 资助金额:
$ 69.36万 - 项目类别:
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction
HIV相关肠上皮屏障功能障碍的分子机制
- 批准号:
10323703 - 财政年份:2021
- 资助金额:
$ 69.36万 - 项目类别:
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction
HIV相关肠上皮屏障功能障碍的分子机制
- 批准号:
10654733 - 财政年份:2021
- 资助金额:
$ 69.36万 - 项目类别:
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction
HIV相关肠上皮屏障功能障碍的分子机制
- 批准号:
10454418 - 财政年份:2021
- 资助金额:
$ 69.36万 - 项目类别:
Molecular mechanisms underlying HIV related intestinal epithelial barrier dysfunction
HIV相关肠上皮屏障功能障碍的分子机制
- 批准号:
10630643 - 财政年份:2021
- 资助金额:
$ 69.36万 - 项目类别:
Development of natural product inhibitors of Nef for clearance of HIV reservoirs
开发 Nef 天然产物抑制剂以清除 HIV 病毒库
- 批准号:
10204722 - 财政年份:2019
- 资助金额:
$ 69.36万 - 项目类别:
Development of natural product inhibitors of Nef for clearance of HIV reservoirs
开发 Nef 天然产物抑制剂以清除 HIV 病毒库
- 批准号:
10772357 - 财政年份:2019
- 资助金额:
$ 69.36万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 69.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 69.36万 - 项目类别:
Operating Grants